Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients-Reference-Cited by-同舟云学术

Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients

Published:2017-12-18 Issue:3 Volume:93 Page:348-355
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Tefferi Ayalew¹^ORCID,Nicolosi Maura¹,Mudireddy Mythri¹^ORCID,Szuber Natasha¹,Finke Christy M.¹,Lasho Terra L.¹,Hanson Curtis A.²,Ketterling Rhett P.³,Pardanani Animesh¹,Gangat Naseema¹^ORCID,Mannarelli Carmela⁴,Fanelli Tiziana⁴,Guglielmelli Paola⁴,Vannucchi Alessandro M.⁴^ORCID

Affiliation:

1. Divisions of Hematology, Departments of Medicine and Laboratory Medicine; Mayo Clinic; Rochester Minnesota

2. Divisions of Hematopathology, Departments of Medicine and Laboratory Medicine; Mayo Clinic; Rochester Minnesota

3. Divisions of Cytogenetics, Departments of Medicine and Laboratory Medicine; Mayo Clinic; Rochester Minnesota

4. Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms; Azienda Ospedaliera Universitaria Careggi, University of Florence; Florence Italy

Publisher

Wiley

Subject

Hematology

Reference42 articles.

1. Myeloproliferative neoplasms: a decade of discoveries and treatment advances;Tefferi;Am J Hematol.,2016

2. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera;James;Nature.,2005

3. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia;Pikman;PLoS Med.,2006

4. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2;Nangalia;N Engl J Med.,2013

5. Somatic mutations of calreticulin in myeloproliferative neoplasms;Klampfl;N Engl J Med.,2013

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes;Clinical Lymphoma Myeloma and Leukemia;2024-07

2. Myelofibrosis and allogeneic transplantation: critical points and challenges;Frontiers in Oncology;2024-06-20

3. Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study;American Journal of Clinical Pathology;2024-04-10

4. First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis;Blood;2024-04-04

5. Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements;Cancers;2024-01-25